This webinar is designed for compounding pharmacy professionals that are looking for best practices to comply with USP <800> regarding sterile compounding of hazardous drugs.

Decontamination of hazardous drugs such as chemotherapy agents from surfaces in compounding areas is essential to reduce the risk of cross-contamination and occupational exposure. In sterile compounding, effective disinfection of microbial contamination also is required. The guidance in USP <800> provides a framework for complying with a mixture of “do's” and “don'ts”. However, there are several aspects of the guidance that still require additional considerations to implement best practices to reduce risk.

This fast-paced webinar will cover several products and processes to reduce hazardous drug residues from receipt to administration. This will include comparisons among different decontamination agents and procedures and how to use the results of wipe sampling to gauge performance. The presentation will include a combination of scientific background and rationale with live demonstrations of key processes related to decontamination and tips, tricks, and caveats for sampling hazardous drug residues.

By watching you will:

• Learn about the “shall”s and “should”s in USP <800>
• Discover and observe the use of products, tools, and procedures that can reduce hazardous drug residues
• Understand how results of wipe sampling can drive improved outcomes

Webinar Resources

• "Hazardous Drugs in Healthcare Settings" PDF Download
• Learn more about USP <800>

Sign up for our Contec Healthcare Newsletter and receive industry information as well as news about upcoming webinars.